These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37267170)

  • 1. Hepatitis C Virus Cascade of Care Among Perinatal Patients in Maine Diagnosed With Opioid Use Disorder, 2015-2020.
    Pfeiffer M; O'Connor A; Zimmerman C; Thakarar K; Ahrens K
    J Addict Med; 2023 May-Jun 01; 17(3):286-293. PubMed ID: 37267170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.
    Page K; Leeman L; Bishop S; Cano S; Bakhireva LN
    Matern Child Health J; 2017 Sep; 21(9):1778-1783. PubMed ID: 28699096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
    Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J
    J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
    Bartlett SR; Wong S; Yu A; Pearce M; MacIsaac J; Nouch S; Adu P; Wilton J; Samji H; Clementi E; Velasquez H; Jeong D; Binka M; Alvarez M; Wong J; Buxton J; Krajden M; Janjua NZ
    Clin Infect Dis; 2022 Mar; 74(4):575-583. PubMed ID: 34125883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
    Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
    Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont.
    Hale AJ; Mathur S; Dejace J; Lidofsky SD
    Public Health Rep; 2023; 138(2):265-272. PubMed ID: 35264027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
    Spaderna M; Kattakuzhy S; Kang SJ; George N; Bijole P; Ebah E; Eyasu R; Ogbumbadiugha O; Silk R; Gannon C; Davis A; Cover A; Gayle B; Narayanan S; Pao M; Kottilil S; Rosenthal E
    Int J Drug Policy; 2023 Jan; 111():103906. PubMed ID: 36384062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
    Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
    Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).
    Talal AH; Markatou M; Sofikitou EM; Brown LS; Perumalswami P; Dinani A; Tobin JN
    Contemp Clin Trials; 2022 Jan; 112():106632. PubMed ID: 34813962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.
    Krans EE; Zickmund SL; Rustgi VK; Park SY; Dunn SL; Schwarz EB
    Subst Abus; 2016; 37(1):88-95. PubMed ID: 26569631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.
    Norton BL; Fleming J; Bachhuber MA; Steinman M; DeLuca J; Cunningham CO; Johnson N; Laraque F; Litwin AH
    Int J Drug Policy; 2017 Sep; 47():196-201. PubMed ID: 28811158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings.
    Ngo BV; James JR; Blalock KL; Jackson SL; Chew LD; Tsui JI
    J Subst Abuse Treat; 2021 Dec; 131():108438. PubMed ID: 34098298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.
    Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ
    J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study.
    Sanvisens A; Rivas I; Faure E; Espinach N; Hernandez-Rubio A; Majó X; Colom J; Muga R
    World J Gastroenterol; 2020 Oct; 26(38):5874-5883. PubMed ID: 33132641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.
    Kramer JR; Puenpatom A; Cao Y; Yu X; El-Serag HB; Kanwal F
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):445-453. PubMed ID: 35077656
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records.
    Häkkinen M; Tourunen J; Pitkänen T; Simojoki K; Vuoti S
    Subst Abuse Treat Prev Policy; 2022 Jun; 17(1):44. PubMed ID: 35655277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
    Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.